ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

NIH To Give 3 Percent Increase to Grants

March 20, 2009

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994

NCI Breast Tissue Registry Available To Researchers

March 24, 1995

McGivney Out at NCCN as Board Cites Management Style, Strategic Direction

January 13, 2012

Frelick Heads ACCC, Kerman Names President-Elect

March 14, 1980